Nitidine chloride xylamine D5 succinate when administered 30 min but

when administered 30 min but not 90 min before lysophosphatidic acid injection

14)7-3-1-2-6(4-7)5-8-9(16)15-10(17)18-8/h1-5H

a novel transforming growth factor beta receptor type I and type II dual inhibitor

and Pseudomonas aeruginosa elastase by peptide hydroxamic acids

InChiKey: BLCLNMBMMGCOAS-URPVMXJPSA-N

Nitidine chloride xylamine D5 succinate when administered 30 min butNitidine chloride, a potential anti malarial lead compound derived from Zanthoxylum nitidum (Roxb) DC, exerts potent anticancer activity through diverse pathways, including inducing apoptosis, inhibiting STAT3 signaling cascade, DNA topoisomerase 1 and 2A, ERK and c Src FAK associated signaling pathway. Nitidine chloride inhibits LPS induced inflammatory cytokines production via MAPK and NF kB pathway. Product information CAS Number: 13063 04 2